Entheogen Therapeutics
Initiative in Mental Health
Entheogen Therapeutics Initiative in Mental Health
Entheogen Therapeutics Initiative
In September 2020, Jaguar Health introduced the Entheogen Therapeutics Initiative (ETI) to support the discovery and advancement of novel, plant-derived medicines acquired from psychoactive plants. These medicines would be developed for the treatment of mood disorders, neurodegenerative diseases, addictions, and other pressing mental health conditions and challenges.

Entheogen Therapeutics Initiative
In September 2020, Jaguar Health introduced the Entheogen Therapeutics Initiative (ETI) to support the discovery and advancement of novel, plant-derived medicines acquired from psychoactive plants. These medicines would be developed for the treatment of mood disorders, neurodegenerative diseases, addictions, and other pressing mental health conditions and challenges.

Our Philosophy in Application

Maximize our proprietary library of approximately 2,300 plants and 3,500 plant extracts with ethnomedicinal investigation

Seek potent, next-generation agents with novel mechanisms of action, and cures versus symptom relief

Pursue collaborations with potential corporate partners whose skillsets and know-how are second to none in the clinical development of psychoactive therapies

First compound identified for possible psychoses/schizophrenia indications

ETI’s scientific strategy team consists of leading and globally renowned ethnobotanists, physicians, and pharmacologists, as well as experts in the fields of natural-product chemistry and neuropharmacology